BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29115578)

  • 1. Characterization of prostate cancer cell progression in zebrafish xenograft model.
    Xu W; Foster BA; Richards M; Bondioli KR; Shah G; Green CC
    Int J Oncol; 2018 Jan; 52(1):252-260. PubMed ID: 29115578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOCS1 inhibits migration and invasion of prostate cancer cells, attenuates tumor growth and modulates the tumor stroma.
    Villalobos-Hernandez A; Bobbala D; Kandhi R; Khan MG; Mayhue M; Dubois CM; Ferbeyre G; Saucier C; Ramanathan S; Ilangumaran S
    Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):36-47. PubMed ID: 27779203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GRP78 Participates in PCA3-regulated Prostate Cancer Progression.
    Lin C; Wang J; Wang Y; Zhu P; Liu X; Li N; Liu J; Yu L; Wang W
    Anticancer Res; 2017 Aug; 37(8):4303-4310. PubMed ID: 28739722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enrichment of human prostate cancer cells with tumor initiating properties in mouse and zebrafish xenografts by differential adhesion.
    Bansal N; Davis S; Tereshchenko I; Budak-Alpdogan T; Zhong H; Stein MN; Kim IY; Dipaola RS; Bertino JR; Sabaawy HE
    Prostate; 2014 Feb; 74(2):187-200. PubMed ID: 24154958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice.
    Angelucci A; Gravina GL; Rucci N; Millimaggi D; Festuccia C; Muzi P; Teti A; Vicentini C; Bologna M
    Endocr Relat Cancer; 2006 Mar; 13(1):197-210. PubMed ID: 16601288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coffee inhibits nuclear factor-kappa B in prostate cancer cells and xenografts.
    Kolberg M; Pedersen S; Mitake M; Holm KL; Bøhn SK; Blomhoff HK; Carlsen H; Blomhoff R; Paur I
    J Nutr Biochem; 2016 Jan; 27():153-63. PubMed ID: 26419686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fangchinoline induced G1/S arrest by modulating expression of p27, PCNA, and cyclin D in human prostate carcinoma cancer PC3 cells and tumor xenograft.
    Wang CD; Huang JG; Gao X; Li Y; Zhou SY; Yan X; Zou A; Chang JL; Wang YS; Yang GX; He GY
    Biosci Biotechnol Biochem; 2010; 74(3):488-93. PubMed ID: 20208355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
    Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLUT1 regulates cell glycolysis and proliferation in prostate cancer.
    Xiao H; Wang J; Yan W; Cui Y; Chen Z; Gao X; Wen X; Chen J
    Prostate; 2018 Feb; 78(2):86-94. PubMed ID: 29105798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nintedanib antiangiogenic inhibitor effectiveness in delaying adenocarcinoma progression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP).
    da Silva RF; Nogueira-Pangrazi E; Kido LA; Montico F; Arana S; Kumar D; Raina K; Agarwal R; Cagnon VHA
    J Biomed Sci; 2017 May; 24(1):31. PubMed ID: 28499383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-talk between alpha1D-adrenoceptors and transient receptor potential vanilloid type 1 triggers prostate cancer cell proliferation.
    Morelli MB; Amantini C; Nabissi M; Liberati S; Cardinali C; Farfariello V; Tomassoni D; Quaglia W; Piergentili A; Bonifazi A; Del Bello F; Santoni M; Mammana G; Servi L; Filosa A; Gismondi A; Santoni G
    BMC Cancer; 2014 Dec; 14():921. PubMed ID: 25481381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate androgen-regulated gene: a novel potential target for androgen-independent prostate cancer therapy.
    Xu XF; Zhou SW; Zhang X; Ye ZQ; Zhang JH; Ma X; Zheng T; Li HZ
    Asian J Androl; 2006 Jul; 8(4):455-62. PubMed ID: 16763722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells.
    Chatterji T; Varkaris AS; Parikh NU; Song JH; Cheng CJ; Schweppe RE; Alexander S; Davis JW; Troncoso P; Friedl P; Kuang J; Lin SH; Gallick GE
    Oncotarget; 2015 Apr; 6(12):10175-94. PubMed ID: 25868388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cigarette smoke modulates PC3 prostate cancer cell migration by altering adhesion molecules and the extracellular matrix.
    Yang S; Long M; Tachado SD; Seng S
    Mol Med Rep; 2015 Nov; 12(5):6990-6. PubMed ID: 26351771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting survivin using a combination of miR‑494 and survivin shRNA has synergistic effects on the suppression of prostate cancer growth.
    Zhu J; Sun C; Wang L; Xu M; Zang Y; Zhou Y; Liu X; Tao W; Xue B; Shan Y; Yang D
    Mol Med Rep; 2016 Feb; 13(2):1602-10. PubMed ID: 26718651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.
    Yang J; Fizazi K; Peleg S; Sikes CR; Raymond AK; Jamal N; Hu M; Olive M; Martinez LA; Wood CG; Logothetis CJ; Karsenty G; Navone NM
    Cancer Res; 2001 Jul; 61(14):5652-9. PubMed ID: 11454720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of prostate cancer cell migration toward bone marrow stromal cell-conditioned medium by Wnt5a signaling.
    Jin F; Qu X; Fan Q; Wang L; Tang T; Hao Y; Dai K
    Mol Med Rep; 2013 Nov; 8(5):1486-92. PubMed ID: 24064566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PSA reduces prostate cancer cell motility by stimulating TRPM8 activity and plasma membrane expression.
    Gkika D; Flourakis M; Lemonnier L; Prevarskaya N
    Oncogene; 2010 Aug; 29(32):4611-6. PubMed ID: 20531306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance.
    Nouri M; Caradec J; Lubik AA; Li N; Hollier BG; Takhar M; Altimirano-Dimas M; Chen M; Roshan-Moniri M; Butler M; Lehman M; Bishop J; Truong S; Huang SC; Cochrane D; Cox M; Collins C; Gleave M; Erho N; Alshalafa M; Davicioni E; Nelson C; Gregory-Evans S; Karnes RJ; Jenkins RB; Klein EA; Buttyan R
    Oncotarget; 2017 Mar; 8(12):18949-18967. PubMed ID: 28145883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intriguing role of fibroblasts and
    Niu YN; Wang K; Jin S; Fan DD; Wang MS; Xing NZ; Xia SJ
    Asian J Androl; 2016; 18(6):913-919. PubMed ID: 26698232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.